Clinical Practice Research Datalink Report issue

Government Phase 4
Founded: London United Kingdom (2012)

Organization Overview

First Clinical Trial
2016
NCT02616666
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Clinical Practice Research Datalink

Active Ingredients

Drugs in Phase 4 Trials (1)

dapagliflozin (farxiga) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1